Table 1-1. Plasma Viremia in... | American Society of Hematology

Table 1-1.

Plasma Viremia in HIV-Infected Hemophiliacs: Follow-up

Patient No.	Spring 1995		Fall 1996
	cRT-PCR^1-1-150 (copies/mL)	Amplicor (copies/mL)	Amplicor (copies/mL)

LTNPs
1	1,750	686	1,580
2	3,840	3,147	9,831
3	8,108	9 867	21,368
4	149	<200	<200
5	1,280	4,675	5,380
6	2,120	4,111	5,955
7	10	−200	−200
Mean	2,465	3,269	6,359
Progressors
8	100,654	74,168	NT
9	9,149	9,275	893
10	1,499,843	667,123	176,946
11	40,537	64,145	162,100
12	18,300	37,190	51,497
13	164,352	41,492	168,968
14	778,870	61,314	Exitus
15	364,467	230,247	Exitus
Mean	284,521	148,119	112,080

Patient No.	Spring 1995		Fall 1996
	cRT-PCR^1-1-150 (copies/mL)	Amplicor (copies/mL)	Amplicor (copies/mL)

LTNPs
1	1,750	686	1,580
2	3,840	3,147	9,831
3	8,108	9 867	21,368
4	149	<200	<200
5	1,280	4,675	5,380
6	2,120	4,111	5,955
7	10	−200	−200
Mean	2,465	3,269	6,359
Progressors
8	100,654	74,168	NT
9	9,149	9,275	893
10	1,499,843	667,123	176,946
11	40,537	64,145	162,100
12	18,300	37,190	51,497
13	164,352	41,492	168,968
14	778,870	61,314	Exitus
15	364,467	230,247	Exitus
Mean	284,521	148,119	112,080

Abbreviation: NT, not tested.

Data from Vicenzi et al.1-1